OptiMedica Corporation Begins U.S. Shipments of the Catalys™ Precision Laser System; First U.S. Patients Treated at Mann Eye Institute, Houston

SANTA CLARA, Calif.--(BUSINESS WIRE)--Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston. Catalys is a next generation laser cataract surgery system that brings unequaled precision and accuracy and a markedly streamlined workflow to the laser cataract procedure. The system was cleared for market by the U.S. Food and Drug Administration in late December 2011.